Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
This JAMA Insights reviews US Food and Drug Administration–approved medications for alcohol use disorder, detailing dosing, efficacy, and adverse effects for naltrexone, acamprosate, and disulfiram.
- Why it matters: Clinicians need clear, consolidated information on approved treatment options for alcohol use disorder to support informed prescribing and patient counseling.
- What they did: The review summarizes FDA-approved medications for alcohol use disorder, focusing on dosing regimens, efficacy outcomes, and adverse effects for naltrexone, acamprosate, and disulfiram.
- The result: The synthesis provides an evidence-based reference on how these three medications are used and what risks they carry for alcohol use disorder.
The findingWhy it mattersWhat they didThe result